Biomarin Pharmaceutical (BMRN) Non-Current Debt (2025 - 2026)
Biomarin Pharmaceutical's Non-Current Debt was $3.53 billion in Q2 2026.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Non-Current Debt (2025 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Debt at Biomarin Pharmaceutical came in at $597.18 million.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.62 Bn | 1,103.20 Bn | 19.71 Bn | 47.86 Bn |
| 2 | Johnson & Johnson | 616.94 Bn | 535.47 Bn | 17.26 Bn | 37.34 Bn |
| 3 | AbbVie | 501.32 Bn | 474.43 Bn | 12.70 Bn | 62.48 Bn |
| 4 | Merck | 367.44 Bn | 321.82 Bn | 12.21 Bn | 51.08 Bn |
| 5 | Novartis Ag | 298.20 Bn | 262.19 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 261.78 Bn | 235.47 Bn | 12.86 Bn | 23.68 Bn |
| 7 | Amgen | 235.70 Bn | 191.10 Bn | 7.24 Bn | 51.86 Bn |
| 8 | Gilead Sciences | 190.88 Bn | 165.07 Bn | 6.22 Bn | 23.83 Bn |
| 9 | Pfizer | 169.72 Bn | 116.36 Bn | 10.94 Bn | 60.50 Bn |
| 10 | Biomarin Pharmaceutical | 10.79 Bn | 4.66 Bn | 786.91 Mn | 3.53 Bn |
API Access
Biomarin Pharmaceutical Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();